Topic: vaccine development
Inovio and GeneOne have started a clinical study of their MERS vaccine in South Korea, where the virus took 36 lives in a 2015 outbreak.
Secretive Moderna shared a new peek into its infectious disease vaccines efforts Thursday.
A phase 3 study shows that Seqirus' MF59-adjuvanted quadrivalent flu vaccine provides better protection in those younger than two years old.
PATH, Walter Reed and GSK have partnered to determine whether tweaking the regimen of Mosquirix could lead to better malaria protection.
Themis secured £3 million from Innovate UK for its Chikungunya vaccine project.
An American university and a group of wealthy libertarians, including Peter Thiel, are backing the offshore testing of an experimental herpes vaccine.
Soligenix just got another $2.5 million awarded from an NIAID contract to support manufacturing of a heat-stable ricin vaccine for future studies.
HHS Secretary Tom Price offered some optimism about a vaccine for addiction, but experts say such it's far from reality.
Merck KGaA’s MilliporeSigma and Baylor College of Medicine joined together to work on vaccines against neglected diseases.
Valneva and Emergent BioSolutions will co-develop a Zika candidate slated to enter phase 1 in late 2017 or early 2018.